← All trials
NCT04599140
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 14, 2020
- Primary completion
- Oct 31, 2024
- Completion date
- Oct 31, 2024
- First posted
- Oct 22, 2020
- Last posted
- Oct 26, 2020
- Enrollment
- 53
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Texas at HoustonLead sponsor
- University of Texas at HoustonOverall official - principal investigator
- Syntrix Biosystems, Inc.Collaborator
- University of Texas at HoustonOfficial
- Bristol-Myers SquibbCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.